Jane Street’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,506
| Closed | -$43.5K | – | 6060 |
|
|
2024
Q1 | $43.5K | Sell |
2,506
-2,781
| -53% | -$48.3K | ﹤0.01% | 5421 |
|
|
2023
Q4 | $67.8K | Buy |
5,287
+4,351
| +465% | +$55.8K | ﹤0.01% | 5344 |
|
|
2023
Q3 | $34.6K | Sell |
936
-16,735
| -95% | -$619K | ﹤0.01% | 4822 |
|
|
2023
Q2 | $711K | Buy |
17,671
+16,941
| +2,321% | +$682K | ﹤0.01% | 3415 |
|
|
2023
Q1 | $52.9K | Sell |
730
-5,190
| -88% | -$376K | ﹤0.01% | 5101 |
|
|
2022
Q4 | $485K | Buy |
5,920
+2,803
| +90% | +$230K | ﹤0.01% | 3431 |
|
|
2022
Q3 | $295K | Buy |
3,117
+2,111
| +210% | +$200K | ﹤0.01% | 4221 |
|
|
2022
Q2 | $195K | Buy |
+1,006
| New | +$195K | ﹤0.01% | 4458 |
|
|
2022
Q1 | – | Sell |
-527
| Closed | -$208K | – | 5612 |
|
|
2021
Q4 | $208K | Sell |
527
-420
| -44% | -$166K | ﹤0.01% | 4376 |
|
|
2021
Q3 | $424K | Buy |
947
+356
| +60% | +$159K | ﹤0.01% | 3610 |
|
|
2021
Q2 | $229K | Sell |
591
-285
| -33% | -$110K | ﹤0.01% | 4297 |
|
|
2021
Q1 | $314K | Sell |
876
-343
| -28% | -$123K | ﹤0.01% | 3867 |
|
|
2020
Q4 | $598K | Sell |
1,219
-3,106
| -72% | -$1.52M | ﹤0.01% | 2583 |
|
|
2020
Q3 | $1.4M | Buy |
4,325
+3,644
| +535% | +$1.18M | ﹤0.01% | 1484 |
|
|
2020
Q2 | $248K | Buy |
+681
| New | +$248K | ﹤0.01% | 3240 |
|
|
2020
Q1 | – | Sell |
-2,273
| Closed | -$936K | – | 3397 |
|
|
2019
Q4 | $936K | Buy |
2,273
+1,377
| +154% | +$567K | ﹤0.01% | 1639 |
|
|
2019
Q3 | $316K | Buy |
+896
| New | +$316K | ﹤0.01% | 2658 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 3237 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3065 |
|
|
2015
Q4 | – | Sell |
-339
| Closed | -$267K | – | 2598 |
|
|
2015
Q3 | $267K | Buy |
+339
| New | +$267K | ﹤0.01% | 1988 |
|